Rep. Mark Green, currently serving in the U.S. Congress representing Tennessee’s 7th district, shared his views on recent developments through a series of tweets. These posts address international agreements, pharmaceutical concerns, and healthcare policies.
On May 2, 2025, Rep. Green commented on an agreement involving President Trump and Ukraine. He described it as a “win-win” scenario where “No more blank checks” are given, emphasizing joint investment in natural resources and continued aid to Ukraine with reciprocal contributions from resource wealth.
In another post dated May 4, 2025, Rep. Green expressed concerns about mifepristone, labeling it a “dangerous drug.” He criticized the Biden administration’s approval process and media coverage by stating that “Mifepristone is a dangerous drug that not only takes the life of an unborn child but also endangers the life of the mother.”
On May 5, 2025, Rep. Green supported calls for healthcare reform by endorsing improvements to the prior authorization process. He agreed with SpecialtyDocs’ view that it is necessary to “meaningfully improve the prior authorization process” to ensure better access to care for patients.
Mark E. Green has been serving in Congress since replacing Marsha Blackburn in 2019 and previously served in the Tennessee Senate from 2013 to 2018.
